ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

PSTV Plus Therapeutics Inc

1.80
0.00 (0.00%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Plus Therapeutics Inc PSTV NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 1.80 14:00:03
Open Price Low Price High Price Close Price Previous Close
1.80 1.80 1.84 1.80 1.80
more quote information »

Recent News

Date Time Source Heading
22/4/202421:00GLOBEPlus Therapeutics Receives $3 Million Award Recommendation..
09/3/202408:30EDGAR2Form S-1/A - General form for registration of securities..
06/3/202408:04EDGAR2Form 8-K - Current report
06/3/202408:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/2/202410:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202410:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202410:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202410:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202410:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202410:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202410:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202410:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202309:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/11/202308:22EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
23/11/202308:08EDGAR2Form S-1 - General form for registration of securities under..
21/11/202316:15EDGAR2Form EFFECT - Notice of Effectiveness
20/11/202323:01EDGAR2Form 8-K - Current report
17/11/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202307:55EDGAR2Form 8-K - Current report
01/11/202307:06EDGAR2Form 8-K - Current report
01/11/202307:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/9/202321:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202321:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/9/202321:00GLOBEPlus Therapeutics Receives $1.9 Million Advance Payment from..
08/9/202321:00GLOBEPlus Therapeutics Enters into License Agreement for..
05/9/202321:00GLOBEPlus Therapeutics Initiates Part B of ReSPECT-LM Phase 1/2a..
30/8/202321:00GLOBEPlus Therapeutics to Present at the H.C. Wainwright 25th..
21/8/202320:05EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15/8/202306:12EDGAR2Form 8-K - Current report
15/8/202306:05GLOBEPlus Therapeutics Reports Second Quarter 2023 Financial..
15/8/202306:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/8/202320:30GLOBEPlus Therapeutics Reports ReSPECT-LM Phase 1 Trial Data at..
09/8/202321:55EDGAR2Form S-1 - General form for registration of securities under..
09/8/202306:05GLOBEPlus Therapeutics to Announce Second Quarter 2023 Financial..
09/8/202301:22GLOBEPlus Therapeutics Announces Key Opinion Leader Roundtable on..
03/8/202321:00GLOBEPlus Therapeutics to Present at the Canaccord Genuity 43rd..
28/7/202306:05GLOBEPlus Therapeutics Strengthens Clinical Program with the..
27/7/202321:00GLOBEPlus Therapeutics to Present at the 2023 SNO/ASCO CNS Cancer..
13/7/202321:00GLOBEPlus Therapeutics to Present at the 2nd Annual Targeted..
29/6/202321:00GLOBEPlus Therapeutics Reports Positive Interim Updates from Two..
14/6/202321:00GLOBEPlus Therapeutics to Participate in the 2023 Healthcare..
08/6/202321:00GLOBEPlus Therapeutics Announces Participation at Upcoming SNO..
01/6/202321:00GLOBEPlus Therapeutics Provides Company Update Today
30/5/202321:00GLOBEPlus Therapeutics Announces Topline Results from Recurrent..
25/5/202321:00GLOBEPlus Therapeutics to Present at the 2023 Virtual June..
16/5/202321:00GLOBEPlus Therapeutics Regains Compliance with Nasdaq Listing..
12/5/202321:00GLOBEPlus Therapeutics to Present in EndBrainCancer Initiative..

Your Recent History

Delayed Upgrade Clock